ADHD Screening

Foundational Context

The ASRS was developed to address the need for a brief, accurate adult ADHD screener that could be used in both clinical and general population settings. Prior to its creation, most ADHD measures were designed for children or required lengthy clinician administration. The ASRS v1.1 was developed with the World Health Organization alongside the revised Composite International Diagnostic Interview, and was validated against blind clinical diagnoses in 154 respondents from the US National Comorbidity Survey Replication (Kessler et al., 2005), demonstrating strong performance as a short screener.

Part A (the 6-item screener) includes items with the highest predictive power for identifying potential ADHD cases. Part B offers a fuller view of symptom frequency but is not used for diagnostic cutoffs. Together, they provide an accessible, structured approach to detecting potential ADHD symptoms in adults who may not have been identified earlier in life.

What the ASRS measures

The ASRS evaluates symptom frequency across core ADHD domains, reflecting DSM-IV/DSM-5-TR criteria for adult presentations. It focuses on the real-world expression of symptoms in daily functioning, including both attentional and hyperactive-impulsive patterns.

The ASRS measures:

• Inattention: difficulty sustaining focus, disorganization, forgetfulness, task avoidance
• Hyperactivity: restlessness, trouble sitting still, excessive activity
• Impulsivity: interrupting, difficulty waiting, acting without thinking
• Task initiation and completion: starting tasks, following through on responsibilities
• Executive functioning challenges: planning, prioritizing, and working memory issues

These domains help clinicians understand whether symptom patterns align with common adult ADHD profiles, without implying diagnostic determination.

How to administer the ASRS

• Self-administered in paper or digital formats
• Designed for quick completion with minimal burden
• Works well in primary care, psychiatry, psychology, and workplace evaluations
• Should be administered when the individual is calm and able to reflect on typical functioning
• For individuals with literacy challenges, clinician-supported administration may be appropriate

ASRS scoring and interpretation

Part A (6-Item Screener):

• A score meeting the published rule (4 or more items in the “elevated frequency” range) suggests the individual is likely to meet criteria for ADHD upon further evaluation.
• This is not a diagnosis, but a validated trigger for deeper assessment.

Part B (12 Symptom Items):

• Provides a broader view of symptom expression and functional impact.
• Higher frequency responses indicate more persistent ADHD-like patterns.
• Clinicians often use Part B to explore domain-specific impairments or to guide interview follow-up.

Global Considerations:

• Self-report may be influenced by mood, stress, insight, or coping mechanisms.
• ADHD symptoms must cause functional impairment to meet diagnostic criteria, the ASRS does not assess impairment directly.
• Elevated scores warrant contextual evaluation through interview, collateral information, and functional assessment.

Psychometric properties

Reliability

• Part A screener internal consistency 0.63–0.72 and test–retest reliability 0.58–0.77 in 668 health plan subscribers (Kessler et al., 2007)
• High test–retest reliability of the screener in adults without ADHD in primary care (Spearman's rho = 0.78; ICC = 0.75; Silverstein et al., 2018)

Validity

• Part A demonstrates moderate sensitivity (68.7%) and excellent specificity (99.5%) for ADHD screening, outperforming the unweighted 18-item ASRS (56.3% and 98.3%) (Kessler et al., 2005)
• Area under the ROC curve of 0.90 against clinician diagnoses in a health plan sample (Kessler et al., 2007)
• Strong convergent validity with clinician-administered ADHD assessments
• Distinguishes well between adults with ADHD and non-ADHD controls
• Factor analyses support its structure across attention and hyperactive-impulsive domains

Kessler et al. (2005) validated the screener against blind clinical DSM-IV ratings in a community sample, contributing to its widespread adoption.

Limitations

• Screening tool only, not diagnostic
• Self-report bias may influence results
• Does not assess age-of-onset criteria or functional impairment (required for diagnosis)
• Not validated for severe cognitive impairment or unstable psychiatric states
• Cultural and linguistic adaptation may affect validity across populations

ADHD Screening Overview

The ASRS is a two-part screener: Part A (6 items) identifies likely ADHD, while Part B (12 items) provides a more detailed symptom assessment. Across both parts it assesses the three core ADHD symptom domains — inattention, hyperactivity, and impulsivity — across all 18 questions. Part A scoring triggers further evaluation, and the full ASRS supports interpretation of symptom patterns.

Documenting ASRS results in clinical notes: The ASRS Part A score and symptom endorsement count belong in the Objective section of your note. See our SOAP notes guide and intake notes guide for templates and examples.

ASRS vs Other ADHD Screening Tools

Choosing the right ADHD assessment depends on your clinical setting and diagnostic needs. Here's how the ASRS compares to other validated ADHD screening tools.

ASRS vs CAARS: World Health Organization-Validated vs Full Assessment

Clinical Guidance: The ASRS is ideal for high-volume screening in primary care or initial mental health intake. Its Part A (6 questions) provides rapid triage with excellent specificity. Use CAARS when you need detailed symptom profiling across subscales or when conducting detailed diagnostic evaluations. Many clinics use ASRS for screening, then follow positive screens with CAARS for detailed assessment.

When to use ASRS: Fast screening, large patient volumes, primary care settings, brief self-report screen needed, initial intake assessment.

ASRS vs WURS: Current vs Childhood Symptoms

Clinical Guidance: The ASRS screens for current adult ADHD symptoms, while the WURS confirms childhood symptom history, a DSM-5-TR requirement for ADHD diagnosis. In full evaluations, use both: ASRS establishes current impairment, WURS verifies early onset. Note that WURS relies on retrospective recall, which can be unreliable; corroboration from childhood records or family is recommended.

When to use both: A complete ADHD diagnosis requires documenting both current symptoms (ASRS) and childhood onset (WURS or clinical interview). The ASRS alone is sufficient for screening and symptom monitoring.

ASRS-6 (Part A Only) vs Full 18-Item ASRS

Clinical Guidance: Part A alone (ASRS-6) is sufficient for screening in high-volume settings, its 99.5% specificity means very few false positives. Use the full 18-item ASRS when you need a detailed symptom breakdown for treatment planning or when monitoring response to ADHD medication. Part B adds nuance but doesn't significantly improve screening accuracy.

Workflow recommendation: Use ASRS-6 (Part A) for initial screening in primary care. If positive, administer full ASRS + clinical interview for diagnostic confirmation. This two-stage approach balances efficiency with diagnostic accuracy.

Simplify ADHD Screening with HiBoop

HiBoop supports measurement-based care for adult ADHD with the WFIRS-S and WURS, with automated scoring and tracking over time.